Buy Cyclopam

Cyclopam

What is Cyclopam?

Cyclopam is a combination pill that contains dicyclomine and paracetamol as its active components. It belongs to the Digestive Health therapeutic class and is formulated as a 20 mg/500 mg tablet. In Hong Kong, Cyclopam is available only by prescription and is marketed by local distributors under the approval of the Hong Kong Department of Health. The medication is used to relieve abdominal cramping and associated pain.

How Cyclopam Works in the Body

• Dicyclomine is an anticholinergic agent. It blocks muscarinic receptors in the smooth muscle of the gastrointestinal (GI) tract, reducing involuntary muscle contractions and relieving spasm. By decreasing the tone of the intestinal wall, it helps alleviate the discomfort of functional bowel disorders.
• Paracetamol (acetaminophen) works centrally by inhibiting the cyclo-oxygenase (COX) pathway, which reduces the synthesis of prostaglandins that mediate pain and fever. Its analgesic effect complements the antispasmodic action of dicyclomine, providing broader pain relief.
• The combined effect leads to faster onset of symptom relief compared with either component alone. Typical onset is within 30-60 minutes, and the duration of action lasts 4-6 hours, matching the dosing interval for most patients.

Conditions Treated by Cyclopam

Cyclopam is approved in Hong Kong for the short-term management of abdominal pain and cramping associated with:

• Functional bowel disorders such as irritable bowel syndrome (IBS)
• Acute gastrointestinal colic (e.g., biliary colic, intestinal spasm)
• Dysmenorrhea when abdominal cramping is a prominent feature

These indications are based on the combined antispasmodic and analgesic properties of the two ingredients. Cyclopam is intended for adult patients; pediatric use is not recommended without specialist supervision.

Patient Suitability and Contraindications

Who Should Use Cyclopam?

• Adults experiencing intermittent abdominal cramps or pain that is not adequately controlled by lifestyle measures alone
• Patients without a history of severe hepatic dysfunction or anticholinergic-sensitive conditions

Absolute Contraindications

• Known hypersensitivity to dicyclomine, paracetamol, or any tablet excipients
• Glaucoma (narrow-angle) or severe ocular hypertension (anticholinergic effect)
• Intestinal obstruction, paralytic ileus, or severe megacolon (risk of worsening blockage)
• Severe hepatic impairment (e.g., Child-Pugh C) due to risk of paracetamol-induced hepatotoxicity

Relative Contraindications

• Pregnancy (especially third trimester) - anticholinergic agents may affect uterine tone; liver metabolism may be altered
• Breastfeeding - paracetamol passes into milk in small amounts; caution advised
• Elderly patients - increased sensitivity to anticholinergic side effects such as dry mouth, urinary retention, and confusion
• Patients with uncontrolled asthma or chronic obstructive pulmonary disease (COPD) - anticholinergic activity may worsen bronchospasm

Special Populations

• Renal impairment: No dose adjustment is required for mild to moderate renal dysfunction, but caution is advised in severe cases.
• Hepatic impairment: Use the lowest effective dose and monitor liver function if therapy is prolonged.

Safety Profile and Interactions

Common Side Effects

• Dry mouth
• Blurred vision
• Constipation
• Dizziness or light-headedness
• Mild nausea (often related to paracetamol)

These effects are usually transient and resolve with continued use or dose adjustment.

Serious Adverse Events

• Severe allergic reactions (rash, angioedema, anaphylaxis)
• Acute hepatitis or elevated liver enzymes with prolonged high-dose paracetamol use
• Acute urinary retention or severe constipation leading to bowel obstruction
• Tachycardia or palpitations secondary to anticholinergic excess

If any of these occur, discontinue Cyclopam and seek immediate medical attention.

Drug Interactions

• Major: Concurrent use of other anticholinergic agents (e.g., trihexyphenidyl, atropine) may intensify dry mouth, blurred vision, and urinary retention.
• Moderate: Warfarin - paracetamol can potentiate anticoagulant effect and increase INR; regular monitoring is recommended.
• Moderate: CYP2D6 inhibitors (e.g., fluoxetine, quinidine) may affect dicyclomine metabolism, potentially raising plasma concentrations.
• Other: MAO-inhibitors and tricyclic antidepressants can increase anticholinergic burden.

Patients should disclose all prescribed medicines, over-the-counter drugs, herbal supplements, and vitamins before starting Cyclopam.

Food and Lifestyle Interactions

• Cyclopam may be taken with or without food; taking it with meals can reduce gastrointestinal irritation from paracetamol.
• Alcohol consumption should be limited, as combined hepatic stress from alcohol and paracetamol may increase the risk of liver injury.
• Caution is advised when operating machinery or driving until the individual’s response to the medication is known, especially if dizziness occurs.

How to Take Cyclopam

• Standard dosing: One 20 mg/500 mg tablet orally, three to four times daily after meals. The exact frequency should be determined by a healthcare provider based on the severity of symptoms.
• Maximum daily dose: Do not exceed four tablets (80 mg/2000 mg) per day unless directed by a physician.
• Renal or hepatic impairment: The prescribing clinician may reduce the total daily amount and monitor liver function tests periodically.
• Administration: Swallow the tablet whole with a full glass of water. Do not crush or chew, as this may affect the release profile.
• Missed dose: Take the missed tablet as soon as remembered unless the next scheduled dose is near; do not double the dose.
• Overdose: Symptoms may include nausea, vomiting, severe abdominal pain, sweating, and confusion. Seek emergency medical care immediately; activated charcoal may be considered, and N-acetylcysteine is the antidote for paracetamol toxicity.
• Discontinuation: No tapering is required for short-term use, but abrupt cessation after prolonged therapy should be discussed with a clinician to avoid rebound abdominal cramps.

Monitoring and Follow-Up

• Liver function tests (LFTs): Baseline and periodic LFTs are advisable for patients on prolonged Cyclopam therapy or those with pre-existing liver disease.
• Symptom review: Patients should schedule follow-up visits within 2-4 weeks of starting therapy to assess efficacy and tolerability.
• Renal assessment: Not routinely required unless the patient has known severe renal disease.

Storage and Handling

• Store tablets at room temperature (15-30 °C), away from excess moisture and direct sunlight.
• Keep the container tightly closed and out of reach of children.
• Do not use the medication after the expiry date printed on the package.
• Dispose of unused tablets according to local pharmacy-based drug-take-back programs or municipal hazardous waste guidelines.

Medication-Specific Glossary

Anticholinergic

A drug that blocks the action of acetylcholine on muscarinic receptors, reducing smooth-muscle spasm and secretions.

COX (Cyclo-oxygenase)

An enzyme involved in the synthesis of prostaglandins; inhibition reduces pain and fever.

Therapeutic Window

The dosage range that provides clinical benefit without unacceptable adverse effects; for Cyclopam, this is defined by the approved 20 mg/500 mg tablet taken up to four times daily.

Medical Disclaimer

This article provides educational information about Cyclopam and is not a substitute for professional medical advice. Treatment decisions, including use for unapproved indications, must be made under the guidance of a qualified healthcare provider. The content is intended for informational purposes and does not constitute medical recommendations. Always consult a physician before starting, stopping, or changing any medication regimen.